WHWK — Whitehawk Therapeutics, Inc. · $202.8M cap

Whitehawk Therapeutics, Inc. (WHWK) is a biotechnology company listed on NASDAQ.

Latest reported WHWK revenue for 2026-06-30 was $0. Net income was -$38.8M. WHWK currently screens at market cap $202.8M.

Use this WHWK page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the WHWK quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the WHWK SEC filings page. Lician reads the product cache first so this HTML stays unique to Whitehawk Therapeutics, Inc. even when a live quote feed is slow.

Whitehawk Therapeutics, Inc. latest statements (FY2025)

Latest cached year on this hub. Full WHWK income, balance, and cash tables.

  • Revenue$7.1M
  • Net Income-$20.6M
  • Total Assets$150.8M
  • Total Debt$0
  • Free Cash Flow-$98.0M

WHWK recent filings